Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Christopher Paul Eckstein
Associate Professor of Neurology
Neurology, MS & Neuroimmunology
christopher.eckstein@duke.edu
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: true}
Recognition
In the News
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
A prospective, multicenter, observational, post-authorization safety study to evaluate the long term safety profile of LEMTRADA® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (PASS)
Clinical Trial
Principal Investigator ·
Awarded by Genzyme Corporation ·
2016 - 2028
Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis
Research
Collaborator ·
Awarded by National Institute of Allergy and Infectious Diseases ·
2021 - 2026
MS Clinical Trial: DUOC
Research
Co Investigator ·
Awarded by The Marcus Foundation ·
2020 - 2025
ECHO MS
Inst. Training Prgm or CME
Collaborator ·
Awarded by National Multiple Sclerosis Society ·
2023 - 2024
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
Clinical Trial
Principal Investigator ·
Awarded by Sanofi US ·
2020 - 2023
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies
Clinical Trial
Principal Investigator ·
Awarded by Biogen, Inc. ·
2018 - 2021
PA Fellowship in Clinical Neuroimmunology
Fellowship
Mentor ·
Awarded by Biogen, Inc. ·
2017 - 2019
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica
Clinical Trial
Principal Investigator ·
Awarded by Alexion Pharmaceuticals, Inc. ·
2015 - 2017
A PHASE III, OPEN-LABEL, EXTENSION TRIAL OF ECU-NMO-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN PATIENTS WITH RELAPSING NEUROMYELITIS OPTICA (NMO)
Clinical Trial
Principal Investigator ·
Awarded by Alexion Pharmaceuticals, Inc. ·
2015 - 2017
